Magnetic Resonance-Guided Ultrasound Surgery of Uterine Leiomyomas

Gynecologic Imaging

Volumn , Issue , 2011, Pages 583-599

  Fennessy, Fiona M ^a   Tempany, Clare M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85062751606     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1575-0.10038-6     Document Type: Chapter

References (27)

1. Stewart E.A. Uterine fibroids. Lancet 2001, 357:293-298.
2. Farquhar C.M., Steiner C.A. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002, 99:229-234.
3. Beinfeld M.T., Bosch J.L., Isaacson K.B., et al. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 2004, 230:207-213.
4. Carls G.S., Lee D.W., Ozminkowski R.J., et al. What are the total costs of surgical treatment for uterine fibroids?. J Womens Health (Larchmt) 2008, 17:1119-1132.
5. Reed S.D., Newton K.M., Thompson L.B., et al. The incidence of repeat uterine surgery following myomectomy. J Womens Health (Larchmt) 2006, 15:1046-1052.
6. Subramanian S., Clark M.A., Isaacson K. Outcome and resource use associated with myomectomy. Obstet Gynecol 2001, 98:583-587.
7. Ravina J.H., Herbreteau D., Ciraru-Vigneron N., et al. Arterial embolisation to treat uterine myomata. Lancet 1995, 346:671-672.
8. Volkers N.A., Hehenkamp W.J., Smit P., et al. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. J Vasc Interv Radiol 2008, 19:1007-1016. quiz 1017.
9. Hirst A., Dutton S., Wu O., et al. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technol Assess 2008, 12:1-248. iii.
10. Lynn J.G., Zwemer R.L., Chick A.J., et al. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942, 26:179-193.
11. Fry W.J., Fry F.J. Fundamental neurological research and human neurosurgery using intense ultrasound. IRE Trans Med Electron 1960, ME-7:166-181.
12. Jolesz F.A., Bleier A.R., Jakab P., et al. MR imaging of laser-tissue interactions. Radiology 1988, 168:249-253.
13. Ishihara Y., Calderon A., Watanabe H., et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med 1995, 34:814-823.
14. Spies J.B., Coyne K., Guaou Guaou N., et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002, 99:290-300.
15. Fennessy F.M., Tempany C.M., McDannold N.J., et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-results of different treatment protocols. Radiology 2007, 243:885-893.
16. Tempany C.M., Stewart E.A., McDannold N., et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003, 226:897-905.
17. Smart O.C., Hindley J.T., Regan L., et al. Magnetic resonance guided focused ultrasound surgery of uterine fibroids-the tissue effects of GnRH agonist pre-treatment. Eur J Radiol 2006, 59:163-167.
18. Zaher S., Gedroyc W.M., Regan L. Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids. Eur J Obstet Gynecol Reprod Biol 2009, 143:98-102.
19. Funaki K., Fukunishi H., Funaki T., et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol 196 2007, 184:e181-e186.
20. McDannold N., Tempany C.M., Fennessy F.M., et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 2006, 240:263-272.
21. Fennessy F.M., Tempany C.M.C., Kong C., et al. Short-term utility analysis of fibroid treatment options and utility analysis of fibroid treatment outcomes 2008, RSNA, Chicago, IL, 433-434.
22. O'Sullivan A.K., Thompson D., Chu P., et al. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care 2009, 25:14-25.
23. Zowall H., Cairns J.A., Brewer C., et al. Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG 2008, 115:653-662.
24. Stewart E.A., Rabinovici J., Tempany C.M., et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006, 85:22-29.
25. Okada A., Morita Y., Fukunishi H., et al. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol 2009, 34:579-583.
26. Leon-Villapalos J., Kaniorou-Larai M., Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns 2005, 31:1054-1055.
27. Rabinovici J, David M, Fukunishi H, et al: Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids, Fertil Steril 93:199-209.